Sanofi S.A. | |
Stock Exchange | Borsa Italiana |
EPS |
EUR2.6 |
Market Cap |
EUR91.71 B |
Shares Outstanding |
1.25 B |
Public Float |
- |
Sanofi | |
Stock Exchange | Other OTC |
EPS |
$4.03 |
Market Cap |
$108.59 B |
Shares Outstanding |
1.25 B |
Public Float |
- |
Sanofi S.A. | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR3.43 |
Market Cap |
EUR97.22 B |
Shares Outstanding |
1.25 B |
Public Float |
- |
Sanofi S.A. ADR | |
Stock Exchange | Mexican Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
2.49 B |
Public Float |
- |
Sanofi ADR | |
Stock Exchange | New York Stock Exchange |
EPS |
$2.02 |
Market Cap |
$108.45 B |
Shares Outstanding |
2.5 B |
Public Float |
2.49 B |
Sanofi S.A. | |
Stock Exchange | Euronext Paris |
EPS |
EUR3.43 |
Market Cap |
EUR97.25 B |
Shares Outstanding |
1.25 B |
Public Float |
1.11 B |
Sanofi S.A. | |
Stock Exchange | SIX Swiss Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
1.25 B |
Public Float |
- |
Address |
54, rue La Boétie Paris Ile-de-France 75008 France |
Employees | - |
Website | http://www.sanofi.com |
Updated | 07/08/2019 |
Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities. |